Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-05-000737
Filing Date
2005-08-03
Accepted
2005-08-03 14:22:35
Documents
1
Period of Report
2005-08-01

Document Format Files

Seq Description Document Type Size
1 paoloform4-080305_ex.html 4  
1 paoloform4-080305_ex.xml 4 7255
  Complete submission text file 0000950162-05-000737.txt   9199
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address VIA SUDAFRICA, 20 ROME A1 00000
CAVAZZA PAOLO (Reporting) CIK: 0001163608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 05995168